Trump signs psychedelic research order

The move follows public advocacy from figures like podcaster Joe Rogan, who recently joined Trump at the White House for the signing ceremony.

Proponents of the order argue that traditional treatments have failed many veterans and that emerging therapies offer a 'breakthrough' for chronic conditions.

However, some health experts have raised concerns about the risks of certain substances, such as ibogaine, which can cause serious heart issues.

The administration maintains that the order will ensure rigorous scientific study while providing new hope for those in need.